U.S. Markets open in 7 hrs 30 mins
  • S&P Futures

    3,800.75
    -16.00 (-0.42%)
     
  • Dow Futures

    31,160.00
    -76.00 (-0.24%)
     
  • Nasdaq Futures

    12,605.75
    -76.00 (-0.60%)
     
  • Russell 2000 Futures

    2,192.90
    -12.90 (-0.58%)
     
  • Crude Oil

    61.58
    +0.30 (+0.49%)
     
  • Gold

    1,715.10
    -0.70 (-0.04%)
     
  • Silver

    26.15
    -0.24 (-0.90%)
     
  • EUR/USD

    1.2064
    -0.0003 (-0.0241%)
     
  • 10-Yr Bond

    1.4700
    0.0000 (0.00%)
     
  • Vix

    26.67
    +2.57 (+10.66%)
     
  • GBP/USD

    1.3961
    +0.0008 (+0.0572%)
     
  • USD/JPY

    107.1160
    +0.1140 (+0.1065%)
     
  • BTC-USD

    49,747.37
    +931.98 (+1.91%)
     
  • CMC Crypto 200

    990.72
    +2.62 (+0.27%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    28,930.11
    -628.99 (-2.13%)
     

ADAMA Reports Second Quarter Results, Returns to Growth Despite COVID-19 Headwinds

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·41 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

BEIJING and TEL AVIV, Israel, Aug. 20, 2020 /PRNewswire/ --

  • Q2 Sales of $1,036 million, +12% at constant exchange rates (CER), +3% in USD (RMB: +8%)
    - Resilient performance driven by 12% volume growth, led by robust growth in emerging markets
    - US dollar sales impacted by an estimated $85 million due to weaker currencies

  • H1 Sales of $2,008 million, +7% in CER terms; in line with 2019 record high in USD (RMB: +4%)
    - Q2 growth bringing a full recovery in H1 sales, with a 10% increase in volumes, despite Q1 COVID-19 challenges
    - US dollar sales impacted by an estimated $135 million due to weaker currencies

  • Q2 EBITDA of $163 million (Q2'19: $177 million); impacted by estimated $61 million in currency headwinds
    - Strong Q2 volume growth alongside improved product mix more than offset by significant currency weakness
    - Maintained tight control of operating expenses, also benefiting from weaker currencies

  • H1 EBITDA of $306 million (H1'19: $365 million); impacted by estimated $94 million in currency headwinds
    - Significant impact of global COVID-19 related currency weakness more than offsetting volume growth and reduction in operating expenses

  • Q2 Net Income of $47 million (Q2'19: $51 million); estimated FX impact of $55 million
    -
    Lower financial expenses only partially mitigating the lower Q2 operating income

  • H1 Net Income of $74 million (H1'19: $131 million); estimated FX impact of $117 million
    - Reduced financial expenses more than offset by higher Q1 tax expense largely due to BRL weakness against USD

ADAMA Ltd. (the "Company") (SZSE 000553), today reported its financial results for the second quarter and six-month period ended June 30, 2020.

Ignacio Dominguez, President and CEO of ADAMA, said, "In these challenging times, we have delivered a second quarter marked by strong underlying business growth, despite the many headwinds posed by the persistent COVID-19 pandemic which has continued to disrupt lives and economies around the globe. While some countries have been able to emerge from pandemic-related shutdowns, many parts of the world continue to see new infections and deaths rising tragically on a daily basis. During this troubling and uncertain period, I am proud of the response of our teams across the world to ensure the health and safety of our employees, and not only to mitigate the impact of the pandemic on our business, but to keep us on a growth trajectory and delivering solutions to farmers. Their efforts have enabled the Company to maintain more than $2 billion in sales in the first half of 2020, despite the challenges posed by COVID-19, including its significant impact on global currencies."

Table 1. Financial Performance Summary

Adjusted, USD (m)

Q2
2020

Q2
2019

%
Change

FX
Impact

%
Change
CER

H1

2020

H1
2019

%
Change

FX
Impact

%
Change
CER

Revenues

1,036

1,002

+3%

-85

+12%

2,008

2,008

0%

-135

+7%

Gross profit

306

327

-7%

-70

+15%

595

673

-12%

-109

+5%

% of sales

29.5%

32.6%







29.6%

33.5%







Operating income (EBIT)

104

116

-10%

-61

+43%

186

242

-23%

-94

+16%

% of sales

10.1%

11.5%







9.3%

12.1%







Net income

47

51

-8%

-55

+100%

74

131

-44%

-117

+46%

% of sales

4.5%

5.1%







3.7%

6.5%







EBITDA

163

177

-8%

-61

+27%

306

365

-16%

-94

+10%

% of sales

15.8%

17.7%







15.2%

18.2%







EPS





















- USD

0.0191

0.0208

-8%





0.0301

0.0535

-44%





- RMB

0.1351

0.1419

-5%





0.2117

0.3626

-42%





CER: Constant Exchange Rates

All income statement items contained in this release are presented on an adjusted basis. EPS are the same for basic and diluted.

These "Adjusted" results exclude items that are of a one-time or non-cash/non-operational nature that do not impact the ongoing performance of the business, and reflects the way the Company's management and the Board of Directors view the performance of the Company internally. The Company believes that excluding the effects of these items from its operating results allows management and investors to effectively compare the true underlying financial performance of its business from period to period and against its global peers.

A summary of these adjustments and a reconciliation between the Adjusted and Reported financials appears below:

Q2

Adjusted

Adjustments

Reported

USD (m)

Q2 2020

Q2 2019

Q2 2020

Q2 2019

Q2 2020

Q2 2019

Revenues

1,036

1,002





1,036

1,002

Gross profit

306

327

0

-1

306

328

Operating income (EBIT)

104

116

16

21

88

95

Income before taxes

62

66

18

20

44

46

Net income

47

51

16

18

31

33

EBITDA

163

177

-5

-3

168

180

Earnings per share

0.0191

0.0208





0.0128

0.0133

H1

Adjusted

Adjustments

Reported

USD (m)

H1 2020

H1 2019

H1 2020

H1 2019

H1 2020

H1 2019

Revenues

2,008

2,008





2,008

2,008

Gross profit

595

673

1

2

593

671

Operating income (EBIT)

186

242

48

51

138

191

Income before taxes

113

155

49

47

64

108

Net income

74

131

45

44

29

87

EBITDA

306

365

5

2

301

363

Earnings per share

0.0301

0.0535





0.0118

0.0355

For a detailed description and analysis of differences between the adjusted income statement and that reported in the financial statements, refer to the appendix to this release.

Performance in Context of Market Environment

During the first half of 2020, the global agrochemical market, amongst many others, was impacted by the unprecedented COVID-19 pandemic. As a result, farmers' incomes have been, and continue to be, negatively impacted in most regions by lower crop prices, reduced demand due to the relative shutdown of the food sector, and labor shortages owing to mobility restrictions, all leading to increased costs for farmers. Governments across the world continue to include farmers in extensive support programs, partially offsetting lost income due to the pandemic.

One of the most widespread economic consequences of the pandemic is the significant weakening of many global currencies against the US dollar, which started abruptly towards the end of Q1 and continued throughout the duration of Q2. This has been seen most notably in the Brazilian Real, Indian Rupee and Turkish Lira, and has contributed to increased volatility in the Euro and Australian dollar.

Following tight supply in the first quarter due to COVID-19 disruptions, chemical production in China has largely returned to prior levels and prices of raw materials and intermediates are starting to reflect such increase in supply. The Company expects to benefit from this trend in the upcoming quarters.

The ongoing spread of the COVID-19 pandemic is expected to continue to impact the performance and profitability of the Company in the coming months. ADAMA continues to actively manage its response to the pandemic in order to ensure the safety of its employees and limit its impact on the Company's business and financial performance.

Becoming Part of the Syngenta Group

In June 2020, ADAMA became a distinctive member of the newly established Syngenta Group. The new group is a world leader in agricultural inputs, spanning crop protection, seeds, fertilizers, additional agricultural and digital technologies, as well as an advanced distribution network in China. ADAMA joined this newly-formed ag-industry leader through the contribution of most of the stake that ChemChina indirectly owned in ADAMA, into the group. As such, there is no change in the Company's ultimate controlling shareholder. ADAMA continues to be headquartered in Israel, and remains traded on the Shenzhen Stock Exchange, and maintains its unique brand and positioning.

B-Share Repurchase Proposal

The overall B-share market in China has suffered for many years from a lack of liquidity and small market size, contributing to the share price of the Company's B-Shares being significantly lower than the net asset value per share. Therefore, in order to enhance investor confidence, and reinforce the Company's commitment to effectively and efficiently return value to its shareholders, the Company's Board of Directors has approved a limited B-share repurchase program. In terms of this program, the Company intends to repurchase up to 26 million of its B-shares (constituting up to 15.6% of the Company's B-shares and up to 1.1% of its total shares outstanding), at an expected cost in the range of approximately $10 million to $20 million. This proposal will be submitted to the Shareholders' Meeting for confirmation in the coming weeks. If confirmed, the program will be completed within three months. The actual timing, number and value of B-shares to be repurchased under the share repurchase program will be determined by the Company's management at its discretion and will depend on a variety of factors, including the market price of the Company's B-shares, general market and economic conditions, and other business considerations.

Financial Highlights

Revenues in the second quarter were $1,036 million, up by 12% in CER terms, driven by robust 12% volume growth, alongside generally stable prices. This performance was achieved despite the various impacts of COVID-19, which continued to pose numerous challenges to the way the Company conducts its business, as well as materially impacting global currencies. In US dollar terms, sales grew by a more moderate 3% (+8% in RMB terms), reflecting an estimated $85 million negative impact from the weaker currencies, and reflecting the Company's strong growth in emerging markets which were among the most significantly impacted by the global currency weakness.

Growth in the second quarter was fueled by a strong performance in emerging markets, most notably in Latin America, with strong volume growth overcoming the material depreciation of regional currencies, as well as in the India, Middle East & Africa region, which benefited from favorable weather. The second quarter also saw a return to growth in China, with a strong recovery from the first quarter's COVID-19 pandemic-related impact on operations at the Company's Jingzhou site in Hubei province. ADAMA also delivered solid growth in Asia-Pacific (outside China), led by a strong performance in Australia.

Sales were lower in both Europe and North America in the second quarter. Steady growth in northern and western Europe only partially compensated for a challenging season seen in central and eastern Europe, where volatile weather posed challenges for growers, reducing planting in some crops earlier in the season, and preventing application in the latter part. In North America, challenging weather reduced purchasing from customers in some US crops, while COVID-19 related uncertainty impacted demand from distribution channels.

The return to growth in the second quarter saw ADAMA generate sales growth of almost 7% in CER terms over the first half of the year, driven by a 10% increase in volumes, while in USD terms the Company was able to match the first-half record-high sales of $2,008 million seen in 2019 (+4% in RMB terms). This reflects the overcoming of an estimated $56 million impact from the COVID-19 pandemic over the first half of the year, as well as the material impact of widespread global currency weakness against the US dollar, which constrained sales in USD terms in the period by an estimated $135 million.

Gross profit in the second quarter was $306 million (gross margin of 29.5%) and $595 million (gross margin of 29.6%) in the first half, compared to $327 million (gross margin of 32.6%) and $673 million (gross margin of 33.5%) in the corresponding periods last year, respectively.

In the second quarter, the strong volume growth alongside somewhat higher prices and an improved product mix were more than offset by the material depreciation of global currencies and slightly higher manufacturing costs. Similarly, over the half-year period, the significant currency weakness and somewhat higher manufacturing costs outweighed the Company's strong volume growth.

The widespread currency depreciation resulting largely from the COVID-19 outbreak constrained gross profit by an estimated $70 million in the quarter. The pandemic impacted H1 gross profit by an estimated $16 million, in addition to an estimated $109 million in currency headwinds.

Operating expenses: Total operating expenses in the second quarter were $202 million (19.5% of sales) and $408 million (20.3% of sales) in the half-year, compared to $211 million (21.1% of sales) and $430 million (21.4% of sales) in the corresponding periods last year, respectively. The Company continues to exercise tight control of its operating expenses, which were also naturally constrained by the impact of COVID-19, and was able to achieve significant savings in the quarter and first half, despite the inclusion of the companies acquired during 2019. Operating expenses in the 2020 periods also benefited from the global currency weakness against the US dollar, while operating expenses in the 2019 periods were net of income related to expropriation of land recorded in those periods.

Operating income in the second quarter was $104 million (10.1% of sales) and $186 million (9.3% of sales) in the first half, compared to $116 million (11.5% of sales) and $242 million (12.1% of sales) in the corresponding periods last year, respectively. The impact of global currency weakness constrained operating income by an estimated $61 million in the quarter and $94 million in the half-year.

EBITDA in the quarter was $163 million (15.8% of sales) and $306 million (15.2% of sales) in the first half, compared to $177 million (17.7% of sales) and $365 million (18.2% of sales) recorded in the corresponding periods last year, respectively. The impact of global currency weakness constrained EBITDA in the second quarter by an estimated $61 million. The COVID-19 pandemic constrained H1 EBITDA by an estimated $15 million, in addition to an estimated $94 million in currency headwinds.

Financial expenses and investment income: Total net financial expenses and investment income were $43 million in the quarter and $74 million in the first half, compared to $49 million and $87 million in the corresponding periods last year, respectively. The lower financial expenses in both the quarter and the half-year largely reflect a reduction in financing costs on the NIS-denominated, CPI-linked bonds due to a lower CPI in Israel.

Tax expenses: Net tax expenses were $15 million in the quarter, in line with those recorded in the second quarter of 2019. In the first half of the year, net tax expenses were $39 million compared to $24 million in the corresponding period last year. The higher tax expenses in the first half are largely due to the first-quarter impact of the weakening of the Brazilian Real against the US dollar, which resulted in non-cash tax expenses due to differences between the functional currency (US dollar) and tax currency (BRL) with respect to the value of non-monetary assets.

Net income in the second quarter was $47 million (4.5% of sales) and $74 million (3.7% of sales) in the first half compared to $51 million (5.1% of sales) and $131 million (6.5% of sales) in the corresponding periods last year. The Company estimates the net impact of the global currency headwinds on Net Income to be $55 million in the second quarter and $117 million in the half year period, in addition to the impact from COVID-19 of an estimated $12 million over the half year period.

Trade working capital at June 30, 2020 was $2,173 million compared to $2,067 million at the same point last year. This moderate increase reflects similar inventory levels alongside higher trade payables, which were more than offset by higher trade receivables, driven largely by the Company's strong growth over the last year in emerging markets, most notably in Latin America and Brazil, where customer credit terms are generally longer.

Cash Flow: Operating cash flow of $229 million was generated in the quarter and $173 million was generated in the first half, compared to $144 million generated and $47 million consumed in the corresponding periods last year, respectively. The improved operating cash flow in both the quarter and first half mainly reflects the improvement in working capital during the periods compared to the parallel periods last year.

Net cash used in investing activities was $62 million in the second quarter and $116 million in the first half, compared to $44 million and $203 million in the corresponding periods last year, respectively. The increase in investments in the second quarter reflect capital investments in infrastructure, including relocations, as well as portfolio expansion, while the higher spend in the 2019 half-year period reflected the acquisition of Bonide in Q1 2019.

Free cash flow of $127 million was generated in the second quarter and $12 million in the first half compared to $59 million generated and $297 million consumed in the corresponding periods last year, respectively, reflecting the improvement in operating cash flow in the second quarter of this year, contrasted with the higher investment levels and acquisitions over the half-year period in 2019.

Leverage: Balance sheet net debt at June 30, 2020 was $1,066 million, compared to $865 million at June 30, 2019, reflecting the 2019 acquisitions and the assumption of their debt, as well as higher capital investment.

Table 2. Regional Sales Performance





Q2 2020

$m

Q2 2019

$m

Change

USD

Change

CER



H1 2020

$m

H1 2019

$m

Change

USD

Change

CER

Europe



252

267

-5.6%

-2.3%



609

628

-3.0%

+0.6%

North America



205

220

-7.0%

-6.5%



373

400

-6.9%

-6.3%

Latin America



220

196

+12.4%

+39.8%



379

355

+6.7%

+27.6%

Asia Pacific



191

173

+11.0%

+16.1%



349

358

-2.4%

+2.7%

Of which China



99

86

+15.6%

+19.8%



168

179

-6.7%

-3.4%

India, Middle East & Africa



167

146

+14.6%

+23.2%



298

267

+11.7%

+18.3%

Total



1,036

1,002

+3.4%

+11.9%



2,008

2,008

+0.0%

+6.7%

CER: Constant Exchange Rates

Europe: Sales were lower by 2.3% in the second quarter but increased slightly in the first half of the year, in CER terms, compared with the corresponding periods last year. The lower sales in the quarter were caused to some extent by higher inventories in the distribution channels remaining from the poor season last year, as well as some advanced purchasing of products generally by distributors in the first quarter of 2020 due to emerging COVID-19 concerns, both of which served to constrain demand and increase pricing pressure.

Steady growth in northern and western Europe, only partially compensated for a challenging season seen in central and eastern Europe, where volatile weather posed challenges for growers, with dry weather reducing planting in some crops earlier in the season, while the sudden wet weather which followed hampered application in the latter part.

On 1 July 2020, ADAMA acquired the remaining 51% stake in Alfa Agricultural Supplies, S.A., a leading Greek provider of crop protection and other agriculture-related inputs. Through this acquisition, ADAMA will further bolster its position and offering in this relevant market by driving the continued development of its value-added product portfolio, deepening Alfa's already strong relationships with local ag-input distributors, retailers and farmers, aiming at meeting the growing needs of farmers in Greece.

In US dollar terms, sales were lower by 5.6% in the quarter and by 3.0% in the half-year period, compared to the corresponding periods last year, also reflecting the net impact of weaker currencies, largely attributed to the COVID-19 outbreak.

North America: Sales were lower by 6.5% in the second quarter and by 6.3% in the first half of the year, in CER terms, compared with the corresponding periods last year. This was largely due to challenging weather conditions, primarily in southern US, which delayed planting and reduced cotton acreage alongside a reduction in cotton demand due to lower retail apparel sales as a result of COVID-19. In addition, COVID-19 related uncertainty saw distributors reducing inventories, putting pressure on prices.

The Company recorded robust growth in Canada, partially offsetting the lower sales in the US, supported by successful product launches including ORIUS® a broad-spectrum herbicide in wheat, barley and oats, PYTHON™ a broad-spectrum, dual mode of action herbicide in field peas and soybeans, as well as LEOPARD®, a fast-acting, selective graminicide for use against grassy weeds in multiple crops.

In US dollar terms, sales were lower by 7.0% in the quarter and by 6.9% in the first half, compared to the corresponding period last year, reflecting the weakening of the Canadian Dollar.

Latin America: Sales grew by 39.8% in the second quarter and by 27.6% in the first half of the year, in CER terms, compared to the corresponding periods last year, driven by significant volume growth in key countries and continued price increases throughout the region.

ADAMA delivered strong growth in Brazil, supported by favorable weather conditions and increased soybean and corn acreage. The Company continues to expand its differentiated product offering in the country, recently launching PLETHORA®, an innovative insecticide mixture with dual mode of action, addressing a broad spectrum of caterpillar and other pests.

Noteworthy performances were also recorded with continued market share gains in Argentina, supported by favorable weather conditions that accelerated the pace of summer crop harvesting and winter grain planting, Peru where the Company's activities were bolstered by its Q4 2019 acquisition in the country, as well as a strong performance in Paraguay.

In US dollar terms, sales in the region grew by 12.4% in the quarter and 6.7% in the first half of the year, compared to the corresponding periods last year, as the robust business growth was heavily impacted by weaker currencies in the region, in particular the significant decline in the Brazilian Real against the US dollar.

Asia-Pacific: Sales grew by 16.1% in the quarter and by 2.7% in the first half of the year, in CER terms, compared to the corresponding periods last year, driven by strong volume growth and continued price increases, recovering from the first quarter COVID-19 impact.

In Asia-Pacific (outside of China), a noteworthy performance was recorded in Australia which has seen a strong season supported by favorable weather. This compensated for challenging seasonal and COVID-19 related conditions in many parts of South East Asia. However, good rice cropping conditions in the region drove increased sales of the Company's leading rice insecticide offering.

During the quarter, the Company obtained multiple new product registrations in the region, including NEGATE®, a dual-mode of action herbicide for use in turf in Australia, GOLTIX GOLD®, a unique herbicide formulation with improved efficacy for controlling weeds in beets in New Zealand, and Banjo Forte®, a fungicide for use in black pepper in Vietnam.

In China, ADAMA saw a strong recovery in business growth in the second quarter, supported by new product launches including XISHENG LV®, a protective fungicide for fruits and vegetables, as well as FEIDIAN #1™, an insecticide for drone application, mainly in rice. This second quarter performance saw the Company almost fully overcoming the loss of sales in the first quarter caused largely by the COVID-19 impact on operations at the Company's Jingzhou site in Hubei province. The second quarter saw a recovery in sales of raw materials and intermediates, albeit at lower prices due to increased supply generally from Chinese producers.

In US dollar terms, sales in the region grew by 11.0% in the second quarter but were lower by 2.4% in the first half of the year, compared to the corresponding periods last year, reflecting the impact of weaker currencies, most notably the Australian Dollar and Chinese Renminbi.

India, Middle East & Africa: Sales grew by 23.2% in the quarter and by 18.3% in the first half of the year, in CER terms, compared to the corresponding periods last year. The Company delivered robust business growth in the region, led by India, alongside continued price increases.

In India, the timely arrival of the monsoon and its associated rains facilitated the good sowing of summer crops, encouraging application of crop protection products, following the lifting of the lockdown imposed by the Indian government. Favorable rainfall in South Africa improved cropping conditions, more than offsetting a challenging cotton season in Turkey.

In US dollar terms, sales in the region grew by 14.6% in the quarter and by 11.7% in the first half of the year, compared to the corresponding periods last year, reflecting the impact of softer currencies, most notably the Turkish Lira, the Indian Rupee and the South African Rand.

Table 3. Revenues by operating segment

Second quarter sales by segment



Q2 2020

USD (m)

%



Q2 2019

USD (m)

%

Crop Protection

941

90.8%



905

90.3%

Intermediates and Ingredients

95

9.2%



97

9.7%

Total

1,036

100.0%



1,002

100.0%

Second quarter sales by product category



Q2 2020

USD (m)

%



Q2 2019

USD (m)

%

Herbicides

446

43.0%



457

45.6%

Insecticides

312

30.2%



275

27.4%

Fungicides

183

17.7%



173

17.3%

Intermediates and Ingredients

95

9.2%



97

9.7%

Total

1,036

100.0%



1,002

100.0%

Note: the sales split by product category is provided for convenience purposes only and is not representative of the way the Company is managed or in which it makes its operational decisions.

First half sales by segment



H1 2020

USD (m)

%



H1 2019

USD (m)

%

Crop Protection

1,825

90.9%



1,814

90.4%

Intermediates and Ingredients

183

9.1%



194

9.6%

Total

2,008

100.0%



2,008

100.0%

First half sales by product category



H1 2020

USD (m)

%



H1 2019

USD (m)

%

Herbicides

886

44.1%



912

45.4%

Insecticides

530

26.4%



547

27.2%

Fungicides

410

20.4%



356

17.7%

Intermediates and Ingredients

183

9.1%



194

9.6%

Total

2,008

100.0%



2,008

100.0%

Note: the sales split by product category is provided for convenience purposes only and is not representative of the way the Company is managed or in which it makes its operational decisions.

Further Information

All filings of the Company, together with a presentation of the key financial highlights of the period, can be accessed through the Company website at www.adama.com.

About ADAMA

ADAMA Ltd. is a global leader in crop protection, providing solutions to farmers across the world to combat weeds, insects and disease. ADAMA has one of the widest and most diverse portfolios of active ingredients in the world, state-of-the art R&D, manufacturing and formulation facilities, together with a culture that empowers our people in markets around the world to listen to farmers and ideate from the field. This uniquely positions ADAMA to offer a vast array of distinctive mixtures, formulations and high-quality differentiated products, delivering solutions that meet local farmer and customer needs in over 100 countries globally. For more information, visit us at www.ADAMA.com and follow us on Twitter® at @ADAMAAgri.

Abridged Consolidated Financial Statements

The following abridged consolidated financial statements and notes have been prepared as described in Note 1. While prepared based on the principles of PRC GAAP, they do not contain all of the information which either PRC GAAP or IFRS would require for a complete set of financial statements and should be read in conjunction with the consolidated financial statements of both ADAMA Ltd. and Adama Agricultural Solutions Ltd. as filed with the Shenzhen and Tel Aviv Stock Exchanges, respectively.

Abridged Consolidated Income Statement for the Second Quarter



Adjusted[1]

Q2 2020

USD (m)

Q2 2019

USD (m)

Q2 2020

RMB (m)

Q2 2019

RMB (m)

Revenues

1,036

1,002

7,339

6,828

Cost of Sales

726

672

5,145

4,577

Business taxes and surcharges

4

3

27

22

Gross profit

306

327

2,167

2,229

% of revenue

29.5%

32.6%

29.5%

32.6%

Selling & Distribution expenses

152

160

1,076

1,092

General & Administrative expenses

33

37

233

248

Research & Development expenses

14

15

97

105

Other

3

-1

23

-4

Total operating expenses

202

211

1,428

1,441

% of revenue

19.5%

21.1%

19.5%

21.1%

Operating income (EBIT)

104

116

739

788

% of revenue

10.1%

11.5%

10.1%

11.5%

Financial expenses and investment income

43

49

303

337

Income before taxes

62

66

436

451

Taxes on Income

15

15

105

104

Net income

47

51

331

347

% of revenue

4.5%

5.1%

4.5%

5.1%

EBITDA

163

177

1,156

1,207

% of revenue

15.8%

17.7%

15.8%

17.7%

Earnings per Share – Basic

0.0191

0.0208

0.1351

0.1419

– Diluted

0.0191

0.0208

0.1351

0.1419

The number of shares used to calculate both basic and diluted earnings per share is 2,446.6 million shares.

Abridged Consolidated Income Statement for the First Half



Adjusted[2]

H1 2020

USD (m)

H1 2019

USD (m)

H1 2020

RMB (m)

H1 2019

RMB (m)

Revenues

2,008

2,008

14,121

13,616

Cost of Sales

1,407

1,329

9,895

9,010

Business taxes and surcharges

7

7

46

46

Gross profit

595

673

4,180

4,560

% of revenue

29.6%

33.5%

29.6%

33.5%

Selling & Distribution expenses

310

324

2,182

2,195

General & Administrative expenses

61

69

427

464

Research & Development expenses

27

31

189

211

Other

10

7

71

49

Total operating expenses

408

430

2,868

2,919

% of revenue

20.3%

21.4%

20.3%

21.4%

Operating income (EBIT)

186

242

1,311

1,641

% of revenue

9.3%

12.1%

9.3%

12.1%

Financial expenses and investment income

74

87

519

589

Income before taxes

113

155

792

1,052

Taxes on Income

39

24

274

165

Net income

74

131

518

887

% of revenue

3.7%

6.5%

3.7%

6.5%

EBITDA

306

365

2,149

2,471

% of revenue

15.2%

18.2%

15.2%

18.1%

Earnings per Share – Basic

0.0301

0.0535

0.2117

0.3626

– Diluted

0.0301

0.0535

0.2117

0.3626

The number of shares used to calculate both basic and diluted earnings per share is 2,446.6 million shares.

Abridged Consolidated Balance Sheet





June 30

2020

USD (m)

June 30

2019

USD (m)



June 30

2020

RMB (m)

June 30

2019

RMB (m)

Assets











Current assets:











Cash at bank and on hand

889

789



6,293

5,425

Bills and accounts receivable

1,367

1,201



9,679

8,254

Inventories

1,500

1,504



10,619

10,338

Other current assets, receivables and prepaid expenses

326

285



2,310

1,959

Total current assets

4,082

3,779



28,901

25,976

Non-current assets:











Fixed assets, net

1,122

1,121



7,941

7,708

Rights of use assets

73

80



516

548

Intangible assets, net

1,437

1,469



10,171

10,102

Deferred tax assets

121

112



857

768

Other non-current assets

100

103



710

708

Total non-current assets

2,853

2,885



20,195

19,834

Total assets

6,935

6,664



49,096

45,810













Liabilities











Current liabilities:











Loans and credit from banks and other lenders

456

397



3,230

2,731

Bills and accounts payable

711

662



5,029

4,554

Other current liabilities

736

767



5,213

5,270

Total current liabilities

1,903

1,826



13,472

12,555

Long-term liabilities:











Loans and credit from banks and other lenders

314

98



2,225

674

Debentures

1,224

1,186



8,664

8,153

Deferred tax liabilities

59

51



416

351

Employee benefits

96

94



676

644

Other long-term liabilities

137

139



973

954

Total long-term liabilities

1,830

1,567



12,954

10,776

Total liabilities

3,733

3,393



26,426

23,331













Equity











Total equity

3,202

3,270



22,670

22,479

Total equity

3,202

3,270



22,670

22,479

Total liabilities and equity

6,935

6,664



49,096

45,810

Abridged Consolidated Cash Flow Statement for the Second Quarter





Q2 2020

USD (m)

Q2 2019

USD (m)



Q2 2020

RMB (m)

Q2 2019

RMB (m)

Cash flow from operating activities:











Cash flow from operating activities

229

144



1,619

985

Cash flow from operating activities

229

144



1,619

985













Investing activities:











Acquisitions of fixed and intangible assets

-63

-47



-446

-319

Cash (paid) received for disposal of investments, net

-7

2



-51

12

Proceeds from disposal of fixed and intangible assets

-

-



-

-

Acquisition of subsidiaries

-

-



-

-2

Other investing activities

6

1



48

9

Cash flow used for investing activities

-62

-44



-442

-300













Financing activities:











Receipt of loans from banks and other lenders

230

66



1,628

451

Repayment of loans from banks and other lenders

-45

-30



-317

-205

Interest payment and other

-44

-42



-311

-288

Other financing activities

-22

-8



-154

-55

Cash flow from (used for) financing activities

119

-14



846

-98

Effects of exchange rate movement on cash and cash equivalents

-

-7



-5

57

Net change in cash and cash equivalents

286

79



2,018

643

Cash and cash equivalents at the beginning of the period

598

704



4,238

4,739

Cash and cash equivalents at the end of the period

884

783



6,256

5,382













Free Cash Flow

127

59



900

404

Abridged Consolidated Cash Flow Statement for the First Half





H1 2020

USD (m)

H1 2019

USD (m)



H1 2020

RMB (m)

H1 2019

RMB (m)

Cash flow from operating activities:











Cash flow from operating activities

173

-47



1,234

-305

Cash flow from operating activities

173

-47



1,234

-305













Investing activities:











Acquisitions of fixed and intangible assets

-114

-89



-803

-606

Cash (paid) received for acquisition of investments, net

-7

3



-51

20

Proceeds from disposal of fixed and intangible assets

2

5



16

31

Acquisition of subsidiaries

-

-123



-

-827

Other investing activities

5

2



39

12

Cash flow used for investing activities

-116

-203



-815

-1,370













Financing activities:











Receipt of loans from banks and other lenders

401

294



2,823

1,988

Repayment of loans from banks and other lenders

-106

-68



-746

-464

Interest payments and other

-50

-52



-357

-351

Other financing activities

-35

-65



-245

-437

Cash flow from (used for) financing activities

210

109



1,475

736

Effects of exchange rate movement on cash and cash equivalents

-3

-2



42

-25

Net change in cash and cash equivalents

264

-142



1,936

-964

Cash and cash equivalents at the beginning of the period

619

925



4,320

6,346

Cash and cash equivalents at the end of the period

883

783



6,256

5,382













Free Cash Flow

12

-297



95

-1,996

Notes to Abridged Consolidated Financial Statements

Note 1: Basis of preparation

Basis of presentation and accounting policies: The abridged consolidated financial statements for the quarters ended June 30, 2020 and 2019 incorporate the financial statements of ADAMA Ltd. and of all of its subsidiaries (the "Company"), including Adama Agricultural Solutions Ltd. ("Solutions") and its subsidiaries.

The Company has adopted the Accounting Standards for Business Enterprises issued by the Ministry of Finance (the "MoF") and the implementation guidance, interpretations and other relevant provisions issued or revised subsequently by the MoF (collectively referred to as "CASBE").

The abridged consolidated financial statements contained in this release are presented in both Chinese Renminbi (RMB), as the Company's shares are traded on the Shenzhen Stock Exchange, as well as in United States dollars ($) as this is the major currency in which the Company's business is conducted. For the purposes of this release, a customary convenience translation has been used for the translation from RMB to US dollars, with Income Statement and Cash Flow items being translated using the quarterly average exchange rate, and Balance Sheet items being translated using the exchange rate at the end of the period.

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated.

Note 2: Abridged Financial Statements

For ease of use, the Financial Statements shown in this release have been abridged as follows:

Abridged Consolidated Income Statement:

  • "Operating expenses" includes selling and distribution expenses; general and administrative expenses; research and development expenses; impairment losses; gain (loss) from disposal of assets and non-operating income and expenses

  • "Financial expenses and investment income" includes net financing expenses; gains from changes in fair value; and investment income (including share of income of equity accounted investees)

Abridged Consolidated Balance Sheet:

  • "Other current assets, receivables and prepaid expenses" includes financial assets held for trading; financial assets in respect of derivatives; prepayments; other receivables; and other current assets

  • "Fixed assets, net" includes fixed assets and construction in progress

  • "Intangible assets, net" includes intangible assets and goodwill

  • "Other non-current assets" includes other equity investments; long-term equity investments; long-term receivables; investment property; and other non-current assets

  • "Loans and credit from banks and other lenders" includes short-term loans and non-current liabilities due within one year

  • "Other current liabilities" includes financial liabilities in respect of derivatives; payables for employee benefits, taxes, interest, dividends and others; advances from customers and other current liabilities

  • "Other long-term liabilities" includes long-term payables, provisions, deferred income and other non-current liabilities

Analysis of Gaps between Adjusted Income Statement and Reported Income Statement in Financial Statements





Q2

Adjusted

Adjustments

Reported

RMB(m)

Q2 2020

Q2 2019

Q2 2020

Q2 2019

Q2 2020

Q2 2019

Revenues

7,339

6,828





7,339

6,828

Gross profit

2,167

2,229

2

-4

2,165

2,233

Operating expenses

1,428

1,441

-116

-145

1,544

1,586

Operating income (EBIT)

739

788

119

141

620

647

Income before taxes

436

451

124

137

312

314

Net income

331

347

110

125

221

222

EBITDA

1,156

1,207

-35

-22

1,191

1,229

Earnings per share

0.1351

0.1419





0.0905

0.0907















H1

Adjusted

Adjustments

Reported

RMB(m)

H1 2020

H1 2019

H1 2020

H1 2019

H1 2020

H1 2019

Revenues

14,121

13,616





14,121

13,616

Gross profit

4,180

4,560

10

13

4,170

4,547

Operating expenses

2,868

2,919

-328

-330

3,196

3,249

Operating income (EBIT)

1,311

1,641

337

343

974

1,298

Income before taxes

792

1,052

343

323

449

729

Net income

518

887

313

298

205

589

EBITDA

2,149

2,471

30

10

2,119

2,461

Earnings per share

0.2117

0.3626





0.0836

0.2406

Income Statement Adjustments







Q2 2020

USD (m)

Q2 2019

USD (m)



Q2 2020

RMB (m)

Q2 2019

RMB (m)

Net Income (Reported)

31.2

32.6



221.4

221.9

Adjustments to COGS & Operating Expenses:











1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash)

11.5

11.5



81.1

78.1

2. Amortization of Transfer assets received and written-up due to 2017 ChemChina-
Syngenta transaction (non-cash)

7.5

9.2



53.3

62.5

3. China Relocation & Upgrade related costs

0.9

2.2



6.5

15.2

4. Long-term incentive (non-cash)

-5.9

-3.3



-41.9

-22.7

5. Amortization of acquisition-related PPA (non-cash)

1.8

1.2



13.1

8.0

6. Employee early retirement expenses

0.9

-



6.4

-

Total Adjustments to Operating Income (EBIT)

16.7

20.7



118.5

141.1

Total Adjustments to EBITDA

-5.0

-3.2



-35.5

-21.6

Adjustments to Financing Expenses:











7. Revaluation of non-cash adjustment related to non-controlling interest

0.8

-0.7



5.6

-4.5

Total Adjustments to Income before Taxes

17.5

20.0



124.2

136.7

Adjustments to Taxes











1. Tax shield on Legacy PPA of 2011 acquisition of Solutions

1.9

1.9



13.8

13.3

5. Deferred tax due to PPA

0.2

-0.3



1.2

-1.9

Total adjustments to Net Income

15.4

18.4



109.2

125.2

Net Income (Adjusted)

46.6

50.9



330.6

347.1



H1 2020

USD (m)

H1 2019

USD (m)



H1 2020

RMB (m)

H1 2019

RMB (m)

Net Income (Reported)

28.8

86.9



204.6

588.6

Adjustments to COGS & Operating Expenses:











1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash)

22.9

22.9



159.7

155.3

2. Amortization of Transfer assets received and written-up due to 2017 ChemChina-
Syngenta transaction (non-cash)

15.4

19.8



107.4

134.2

3. China Relocation & Upgrade related costs

1.8

4.5



12.8

30.7

4. Long-term incentive (non-cash)

-5.2

1.4



-36.8

9.2

5. Amortization of acquisition-related PPA (non-cash)

3.7

2.1



28.1

14.1

6. Employee early retirement expenses

9.5

-



66.2

-

Total Adjustments to Operating Income (EBIT)

48.1

50.7



337.4

343.5

Total Adjustments to EBITDA

4.3

1.6



29.4

10.2

Adjustments to Financing Expenses:











7. Revaluation of non-cash adjustment related to non-controlling interest

0.8

-3.0



5.6

-20.5

Total Adjustments to Income before Taxes

48.9

47.7



343.0

322.9

Adjustments to Taxes











1. Tax shield on Legacy PPA of 2011 acquisition of Solutions

3.9

3.9



27.2

26.4

5. Deferred tax due to PPA

0.3

-0.3



2.5

-1.9

Total adjustments to Net Income

44.7

44.1



313.3

298.4

Net Income (Adjusted)

73.5

131.0



518.0

887.1

Notes:

1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash): Under PRC GAAP, the Company has inherited the historical "legacy" amortization charge from the first combined reporting for Q3 2017 that ChemChina previously was incurring in respect of its acquisition of Solutions in 2011. This amortization is done in a linear manner on a quarterly basis, most of which will be completed and removed in the second half of 2020.

2. Amortization of Transfer assets received and written-up due to 2017 ChemChina-Syngenta transaction (non-cash): The proceeds from the Divestment of crop protection products in connection with the approval by the EU Commission of the acquisition of Syngenta by ChemChina, net of taxes and transaction expenses, were paid to Syngenta in return for the transfer of a portfolio of products in Europe of similar nature and economic value. Since the products acquired from Syngenta are of the same nature and with the same net economic value as those divested, and since in 2018 the Company excluded the one-time gain that it made on the divested products, the additional amortization charge incurred due to the written-up value of the acquired assets is also excluded to present a consistent view of Divestment and Transfer transactions, which had no net impact on the underlying economic performance of the Company. These additional amortization charges will continue until 2032 but at a reducing rate, yet will still be at a meaningful level (more than $10 million per year) until 2028.

3. China Relocation & Upgrade related costs: These are non-cash accelerated depreciation charges related to the three-year Relocation & Upgrade program in China. Production assets located in the old production sites in Jingzhou and Huai'An will be relocated to the new sites in the coming years. Since some of the older production assets may not be able to be relocated, their economic life has been shortened and therefore will be depreciated over a shorter period. Since these are older assets that were built many years ago and will be replaced by newer production facilities at the new sites, and since the ongoing operations of the business will not be impacted thereby, the Company adjusts for the impact of the accelerated depreciation of these assets.

4. Long-term Incentive (non-cash): The Company granted its employees, who are mainly non-Chinese residents, a long-term incentive (LTI) in the form of 'phantom' options, due to the complexity of granting Chinese-listed, equity-settled options to non-Chinese employees. As such, the Company records an expense, or recognizes income, depending on the fluctuation in the Company's share price, even though the Company will not incur any cash impact prior to exercise of the phantom options. To neutralize the impact of such share price movements on the measurement of the Company's performance and expected employee compensation and to reflect the existing phantom options, in the Company's adjusted financial performance, the LTI is presented on an equity-settled basis in accordance with the value of the existing plan at the grant date.

5. Amortization of acquisition-related PPA (non-cash): Related to the amortization of non-cash intangible assets created as part of the allocation of the purchase price (PPA) on acquisitions; has no impact on the ongoing performance of the companies acquired.

6. Employee early retirement expenses: Provision for early retirement plan of employees at the Company's Israeli manufacturing sites

7. Revaluation of non-cash adjustment related to non-controlling interest: Relates to put options issued to non-controlling interests as part of historical business combinations which took place before January 1, 2010. The put options are presented as a liability at the present value of the future exercise price. The revaluation of these put options in Solutions is recognized under IFRS to Goodwill, but due to the acquisition of Solutions by the Company in 2017, which is treated from an accounting perspective as a "Business Combination Under Common Control", such revaluation is recorded as a profit or loss item in the financial reports of the Company. The revaluations of such put options have no bearing on the ongoing performance of the Company and are therefore adjusted for.

Exchange Rate Data for the Company's Principal Functional Currencies







June 30



Q2 Average



H1 Average

2020

2019

Change



2020

2019

Change



2020

2019

Change

EUR/USD

1.120

1.138

(1.5%)



1.100

1.124

(2.2%)



1.101

1.130

(2.6%)

USD/BRL

5.476

3.832

(42.9%)



5.839

3.919

(37.5%)



4.923

3.845

(28.1%)

USD/PLN

3.981

3.734

(6.6%)



4.096

3.812

(7.5%)



4.008

3.801

(5.5%)

USD/ZAR

17.241

14.140

(21.9%)



17.976

14.407

(24.8%)



16.664

14.213

(17.2%)

AUD/USD

0.684

0.703

(2.6%)



0.655

0.700

(6.5%)



0.656

0.706

(7.1%)

GBP/USD

1.227

1.270

(3.4%)



1.241

1.285

(3.5%)



1.260

1.294

(2.6%)

USD/ILS

3.466

3.566

2.8%



3.516

3.595

2.2%



3.507

3.620

3.1%

USD LIBOR 3M

0.30%

2.32%

(87.0%)



0.60%

2.51%

(76.1%)



1.08%

2.69%

(59.9%)



June 30



Q2 Average



H1 Average

2020

2019

Change



2020

2019

Change



2020

2019

Change

USD/RMB

7.080

6.875

3.0%



7.085

6.816

3.9%



7.029

6.780

3.7%

EUR/RMB

7.931

7.821

1.4%



7.791

7.661

1.7%



7.739

7.661

1.0%

RMB/BRL

0.774

0.557

(38.8%)



0.761

0.575

(32.3%)



0.700

0.567

(23.5%)

RMB/PLN

0.562

0.543

(3.5%)



0.559

0.559

0.0%



0.570

0.561

(1.7%)

RMB/ZAR

0.411

0.486

15.5%



0.394

0.473

16.7%



0.422

0.477

11.6%

AUD/RMB

4.846

4.832

0.3%



4.638

4.773

(2.8%)



4.612

4.790

(3.7%)

GBP/RMB

8.689

8.734

(0.5%)



8.790

8.762

0.3%



8.857

8.773

1.0%

RMB/ILS

0.490

0.519

5.6%



0.496

0.527

5.9%



0.499

0.534

6.6%

[1] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below "Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements".

[2] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below "Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements".

Contact



Ben Cohen

Zhujun Wang

Global Investor Relations

China Investor Relations

Email: ir@adama.com

Email: irchina@adama.com

SOURCE ADAMA Ltd.


Related Links

http://www.adama.com/

27.4%

Fungicides

183

17.7%


173

17.3%

Intermediates and Ingredients

95

9.2%


97

9.7%

Total

1,036

100.0%


1,002

100.0%

Note: the sales split by product category is provided for convenience purposes only and is not representative of the way the Company is managed or in which it makes its operational decisions.

First half sales by segment


H1 2020

USD (m)

%


H1 2019

USD (m)

%

Crop Protection

1,825

90.9%


1,814

90.4%

Intermediates and Ingredients

183

9.1%


194

9.6%

Total

2,008

100.0%


2,008

100.0%

First half sales by product category


H1 2020

USD (m)

%


H1 2019

USD (m)

%

Herbicides

886

44.1%


912

45.4%

Insecticides

530

26.4%


547

27.2%

Fungicides

410

20.4%


356

17.7%

Intermediates and Ingredients

183

9.1%


194

9.6%

Total

2,008

100.0%


2,008

100.0%

Note: the sales split by product category is provided for convenience purposes only and is not representative of the way the Company is managed or in which it makes its operational decisions.

Further Information

All filings of the Company, together with a presentation of the key financial highlights of the period, can be accessed through the Company website at www.adama.com.

About ADAMA

ADAMA Ltd. is a global leader in crop protection, providing solutions to farmers across the world to combat weeds, insects and disease. ADAMA has one of the widest and most diverse portfolios of active ingredients in the world, state-of-the art R&D, manufacturing and formulation facilities, together with a culture that empowers our people in markets around the world to listen to farmers and ideate from the field. This uniquely positions ADAMA to offer a vast array of distinctive mixtures, formulations and high-quality differentiated products, delivering solutions that meet local farmer and customer needs in over 100 countries globally. For more information, visit us at www.ADAMA.com and follow us on Twitter® at @ADAMAAgri.

Abridged Consolidated Financial Statements

The following abridged consolidated financial statements and notes have been prepared as described in Note 1. While prepared based on the principles of PRC GAAP, they do not contain all of the information which either PRC GAAP or IFRS would require for a complete set of financial statements and should be read in conjunction with the consolidated financial statements of both ADAMA Ltd. and Adama Agricultural Solutions Ltd. as filed with the Shenzhen and Tel Aviv Stock Exchanges, respectively.

Abridged Consolidated Income Statement for the Second Quarter


Adjusted[1]

Q2 2020

USD (m)

Q2 2019

USD (m)

Q2 2020

RMB (m)

Q2 2019

RMB (m)

Revenues

1,036

1,002

7,339

6,828

Cost of Sales

726

672

5,145

4,577

Business taxes and surcharges

4

3

27

22

Gross profit

306

327

2,167

2,229

% of revenue

29.5%

32.6%

29.5%

32.6%

Selling & Distribution expenses

152

160

1,076

1,092

General & Administrative expenses

33

37

233

248

Research & Development expenses

14

15

97

105

Other

3

-1

23

-4

Total operating expenses

202

211

1,428

1,441

% of revenue

19.5%

21.1%

19.5%

21.1%

Operating income (EBIT)

104

116

739

788

% of revenue

10.1%

11.5%

10.1%

11.5%

Financial expenses and investment income

43

49

303

337

Income before taxes

62

66

436

451

Taxes on Income

15

15

105

104

Net income

47

51

331

347

% of revenue

4.5%

5.1%

4.5%

5.1%

EBITDA

163

177

1,156

1,207

% of revenue

15.8%

17.7%

15.8%

17.7%

Earnings per Share – Basic

0.0191

0.0208

0.1351

0.1419

– Diluted

0.0191

0.0208

0.1351

0.1419

The number of shares used to calculate both basic and diluted earnings per share is 2,446.6 million shares.

Abridged Consolidated Income Statement for the First Half


Adjusted[2]

H1 2020

USD (m)

H1 2019

USD (m)

H1 2020

RMB (m)

H1 2019

RMB (m)

Revenues

2,008

2,008

14,121

13,616

Cost of Sales

1,407

1,329

9,895

9,010

Business taxes and surcharges

7

7

46

46

Gross profit

595

673

4,180

4,560

% of revenue

29.6%

33.5%

29.6%

33.5%

Selling & Distribution expenses

310

324

2,182

2,195

General & Administrative expenses

61

69

427

464

Research & Development expenses

27

31

189

211

Other

10

7

71

49

Total operating expenses

408

430

2,868

2,919

% of revenue

20.3%

21.4%

20.3%

21.4%

Operating income (EBIT)

186

242

1,311

1,641

% of revenue

9.3%

12.1%

9.3%

12.1%

Financial expenses and investment income

74

87

519

589

Income before taxes

113

155

792

1,052

Taxes on Income

39

24

274

165

Net income

74

131

518

887

% of revenue

3.7%

6.5%

3.7%

6.5%

EBITDA

306

365

2,149

2,471

% of revenue

15.2%

18.2%

15.2%

18.1%

Earnings per Share – Basic

0.0301

0.0535

0.2117

0.3626

– Diluted

0.0301

0.0535

0.2117

0.3626

The number of shares used to calculate both basic and diluted earnings per share is 2,446.6 million shares.

Abridged Consolidated Balance Sheet



June 30

2020

USD (m)

June 30

2019

USD (m)


June 30

2020

RMB (m)

June 30

2019

RMB (m)

Assets






Current assets:






Cash at bank and on hand

889

789


6,293

5,425

Bills and accounts receivable

1,367

1,201


9,679

8,254

Inventories

1,500

1,504


10,619

10,338

Other current assets, receivables and prepaid expenses

326

285


2,310

1,959

Total current assets

4,082

3,779


28,901

25,976

Non-current assets:






Fixed assets, net

1,122

1,121


7,941

7,708

Rights of use assets

73

80


516

548

Intangible assets, net

1,437

1,469


10,171

10,102

Deferred tax assets

121

112


857

768

Other non-current assets

100

103


710

708

Total non-current assets

2,853

2,885


20,195

19,834

Total assets

6,935

6,664


49,096

45,810







Liabilities






Current liabilities:






Loans and credit from banks and other lenders

456

397


3,230

2,731

Bills and accounts payable

711

662


5,029

4,554

Other current liabilities

736

767


5,213

5,270

Total current liabilities

1,903

1,826


13,472

12,555

Long-term liabilities:






Loans and credit from banks and other lenders

314

98


2,225

674

Debentures

1,224

1,186


8,664

8,153

Deferred tax liabilities

59

51


416

351

Employee benefits

96

94


676

644

Other long-term liabilities

137

139


973

954

Total long-term liabilities

1,830

1,567


12,954

10,776

Total liabilities

3,733

3,393


26,426

23,331







Equity






Total equity

3,202

3,270


22,670

22,479

Total equity

3,202

3,270


22,670

22,479

Total liabilities and equity

6,935

6,664


49,096

45,810

Abridged Consolidated Cash Flow Statement for the Second Quarter



Q2 2020

USD (m)

Q2 2019

USD (m)


Q2 2020

RMB (m)

Q2 2019

RMB (m)

Cash flow from operating activities:






Cash flow from operating activities

229

144


1,619

985

Cash flow from operating activities

229

144


1,619

985







Investing activities:






Acquisitions of fixed and intangible assets

-63

-47


-446

-319

Cash (paid) received for disposal of investments, net

-7

2


-51

12

Proceeds from disposal of fixed and intangible assets

-

-


-

-

Acquisition of subsidiaries

-

-


-

-2

Other investing activities

6

1


48

9

Cash flow used for investing activities

-62

-44


-442

-300







Financing activities:






Receipt of loans from banks and other lenders

230

66


1,628

451

Repayment of loans from banks and other lenders

-45

-30


-317

-205

Interest payment and other

-44

-42


-311

-288

Other financing activities

-22

-8


-154

-55

Cash flow from (used for) financing activities

119

-14


846

-98

Effects of exchange rate movement on cash and cash equivalents

-

-7


-5

57

Net change in cash and cash equivalents

286

79


2,018

643

Cash and cash equivalents at the beginning of the period

598

704


4,238

4,739

Cash and cash equivalents at the end of the period

884

783


6,256

5,382







Free Cash Flow

127

59


900

404

Abridged Consolidated Cash Flow Statement for the First Half



H1 2020

USD (m)

H1 2019

USD (m)


H1 2020

RMB (m)

H1 2019

RMB (m)

Cash flow from operating activities:






Cash flow from operating activities

173

-47


1,234

-305

Cash flow from operating activities

173

-47


1,234

-305







Investing activities:






Acquisitions of fixed and intangible assets

-114

-89


-803

-606

Cash (paid) received for acquisition of investments, net

-7

3


-51

20

Proceeds from disposal of fixed and intangible assets

2

5


16

31

Acquisition of subsidiaries

-

-123


-

-827

Other investing activities

5

2


39

12

Cash flow used for investing activities

-116

-203


-815

-1,370







Financing activities:






Receipt of loans from banks and other lenders

401

294


2,823

1,988

Repayment of loans from banks and other lenders

-106

-68


-746

-464

Interest payments and other

-50

-52


-357

-351

Other financing activities

-35

-65


-245

-437

Cash flow from (used for) financing activities

210

109


1,475

736

Effects of exchange rate movement on cash and cash equivalents

-3

-2


42

-25

Net change in cash and cash equivalents

264

-142


1,936

-964

Cash and cash equivalents at the beginning of the period

619

925


4,320

6,346

Cash and cash equivalents at the end of the period

883

783


6,256

5,382







Free Cash Flow

12

-297


95

-1,996

Notes to Abridged Consolidated Financial Statements

Note 1: Basis of preparation

Basis of presentation and accounting policies: The abridged consolidated financial statements for the quarters ended June 30, 2020 and 2019 incorporate the financial statements of ADAMA Ltd. and of all of its subsidiaries (the "Company"), including Adama Agricultural Solutions Ltd. ("Solutions") and its subsidiaries.

The Company has adopted the Accounting Standards for Business Enterprises issued by the Ministry of Finance (the "MoF") and the implementation guidance, interpretations and other relevant provisions issued or revised subsequently by the MoF (collectively referred to as "CASBE").

The abridged consolidated financial statements contained in this release are presented in both Chinese Renminbi (RMB), as the Company's shares are traded on the Shenzhen Stock Exchange, as well as in United States dollars ($) as this is the major currency in which the Company's business is conducted. For the purposes of this release, a customary convenience translation has been used for the translation from RMB to US dollars, with Income Statement and Cash Flow items being translated using the quarterly average exchange rate, and Balance Sheet items being translated using the exchange rate at the end of the period.

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated.

Note 2: Abridged Financial Statements

For ease of use, the Financial Statements shown in this release have been abridged as follows:

Abridged Consolidated Income Statement:

  • "Operating expenses" includes selling and distribution expenses; general and administrative expenses; research and development expenses; impairment losses; gain (loss) from disposal of assets and non-operating income and expenses

  • "Financial expenses and investment income" includes net financing expenses; gains from changes in fair value; and investment income (including share of income of equity accounted investees)

Abridged Consolidated Balance Sheet:

  • "Other current assets, receivables and prepaid expenses" includes financial assets held for trading; financial assets in respect of derivatives; prepayments; other receivables; and other current assets

  • "Fixed assets, net" includes fixed assets and construction in progress

  • "Intangible assets, net" includes intangible assets and goodwill

  • "Other non-current assets" includes other equity investments; long-term equity investments; long-term receivables; investment property; and other non-current assets

  • "Loans and credit from banks and other lenders" includes short-term loans and non-current liabilities due within one year

  • "Other current liabilities" includes financial liabilities in respect of derivatives; payables for employee benefits, taxes, interest, dividends and others; advances from customers and other current liabilities

  • "Other long-term liabilities" includes long-term payables, provisions, deferred income and other non-current liabilities

Analysis of Gaps between Adjusted Income Statement and Reported Income Statement in Financial Statements



Q2

Adjusted

Adjustments

Reported

RMB(m)

Q2 2020

Q2 2019

Q2 2020

Q2 2019

Q2 2020

Q2 2019

Revenues

7,339

6,828



7,339

6,828

Gross profit

2,167

2,229

2

-4

2,165

2,233

Operating expenses

1,428

1,441

-116

-145

1,544

1,586

Operating income (EBIT)

739

788

119

141

620

647

Income before taxes

436

451

124

137

312

314

Net income

331

347

110

125

221

222

EBITDA

1,156

1,207

-35

-22

1,191

1,229

Earnings per share

0.1351

0.1419



0.0905

0.0907








H1

Adjusted

Adjustments

Reported

RMB(m)

H1 2020

H1 2019

H1 2020

H1 2019

H1 2020

H1 2019

Revenues

14,121

13,616



14,121

13,616

Gross profit

4,180

4,560

10

13

4,170

4,547

Operating expenses

2,868

2,919

-328

-330

3,196

3,249

Operating income (EBIT)

1,311

1,641

337

343

974

1,298

Income before taxes

792

1,052

343

323

449

729

Net income

518

887

313

298

205

589

EBITDA

2,149

2,471

30

10

2,119

2,461

Earnings per share

0.2117

0.3626



0.0836

0.2406

Income Statement Adjustments




Q2 2020

USD (m)

Q2 2019

USD (m)


Q2 2020

RMB (m)

Q2 2019

RMB (m)

Net Income (Reported)

31.2

32.6


221.4

221.9

Adjustments to COGS & Operating Expenses:






1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash)

11.5

11.5


81.1

78.1

2. Amortization of Transfer assets received and written-up due to 2017 ChemChina-
Syngenta transaction (non-cash)

7.5

9.2


53.3

62.5

3. China Relocation & Upgrade related costs

0.9

2.2


6.5

15.2

4. Long-term incentive (non-cash)

-5.9

-3.3


-41.9

-22.7

5. Amortization of acquisition-related PPA (non-cash)

1.8

1.2


13.1

8.0

6. Employee early retirement expenses

0.9

-


6.4

-

Total Adjustments to Operating Income (EBIT)

16.7

20.7


118.5

141.1

Total Adjustments to EBITDA

-5.0

-3.2


-35.5

-21.6

Adjustments to Financing Expenses:






7. Revaluation of non-cash adjustment related to non-controlling interest

0.8

-0.7


5.6

-4.5

Total Adjustments to Income before Taxes

17.5

20.0


124.2

136.7

Adjustments to Taxes






1. Tax shield on Legacy PPA of 2011 acquisition of Solutions

1.9

1.9


13.8

13.3

5. Deferred tax due to PPA

0.2

-0.3


1.2

-1.9

Total adjustments to Net Income

15.4

18.4


109.2

125.2

Net Income (Adjusted)

46.6

50.9


330.6

347.1


H1 2020

USD (m)

H1 2019

USD (m)


H1 2020

RMB (m)

H1 2019

RMB (m)

Net Income (Reported)

28.8

86.9


204.6

588.6

Adjustments to COGS & Operating Expenses:






1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash)

22.9

22.9


159.7

155.3

2. Amortization of Transfer assets received and written-up due to 2017 ChemChina-
Syngenta transaction (non-cash)

15.4

19.8


107.4

134.2

3. China Relocation & Upgrade related costs

1.8

4.5


12.8

30.7

4. Long-term incentive (non-cash)

-5.2

1.4


-36.8

9.2

5. Amortization of acquisition-related PPA (non-cash)

3.7

2.1


28.1

14.1

6. Employee early retirement expenses

9.5

-


66.2

-

Total Adjustments to Operating Income (EBIT)

48.1

50.7


337.4

343.5

Total Adjustments to EBITDA

4.3

1.6


29.4

10.2

Adjustments to Financing Expenses:






7. Revaluation of non-cash adjustment related to non-controlling interest

0.8

-3.0


5.6

-20.5

Total Adjustments to Income before Taxes

48.9

47.7


343.0

322.9

Adjustments to Taxes






1. Tax shield on Legacy PPA of 2011 acquisition of Solutions

3.9

3.9


27.2

26.4

5. Deferred tax due to PPA

0.3

-0.3


2.5

-1.9

Total adjustments to Net Income

44.7

44.1


313.3

298.4

Net Income (Adjusted)

73.5

131.0


518.0

887.1

Notes:

1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash): Under PRC GAAP, the Company has inherited the historical "legacy" amortization charge from the first combined reporting for Q3 2017 that ChemChina previously was incurring in respect of its acquisition of Solutions in 2011. This amortization is done in a linear manner on a quarterly basis, most of which will be completed and removed in the second half of 2020.

2. Amortization of Transfer assets received and written-up due to 2017 ChemChina-Syngenta transaction (non-cash): The proceeds from the Divestment of crop protection products in connection with the approval by the EU Commission of the acquisition of Syngenta by ChemChina, net of taxes and transaction expenses, were paid to Syngenta in return for the transfer of a portfolio of products in Europe of similar nature and economic value. Since the products acquired from Syngenta are of the same nature and with the same net economic value as those divested, and since in 2018 the Company excluded the one-time gain that it made on the divested products, the additional amortization charge incurred due to the written-up value of the acquired assets is also excluded to present a consistent view of Divestment and Transfer transactions, which had no net impact on the underlying economic performance of the Company. These additional amortization charges will continue until 2032 but at a reducing rate, yet will still be at a meaningful level (more than $10 million per year) until 2028.

3. China Relocation & Upgrade related costs: These are non-cash accelerated depreciation charges related to the three-year Relocation & Upgrade program in China. Production assets located in the old production sites in Jingzhou and Huai'An will be relocated to the new sites in the coming years. Since some of the older production assets may not be able to be relocated, their economic life has been shortened and therefore will be depreciated over a shorter period. Since these are older assets that were built many years ago and will be replaced by newer production facilities at the new sites, and since the ongoing operations of the business will not be impacted thereby, the Company adjusts for the impact of the accelerated depreciation of these assets.

4. Long-term Incentive (non-cash): The Company granted its employees, who are mainly non-Chinese residents, a long-term incentive (LTI) in the form of 'phantom' options, due to the complexity of granting Chinese-listed, equity-settled options to non-Chinese employees. As such, the Company records an expense, or recognizes income, depending on the fluctuation in the Company's share price, even though the Company will not incur any cash impact prior to exercise of the phantom options. To neutralize the impact of such share price movements on the measurement of the Company's performance and expected employee compensation and to reflect the existing phantom options, in the Company's adjusted financial performance, the LTI is presented on an equity-settled basis in accordance with the value of the existing plan at the grant date.

5. Amortization of acquisition-related PPA (non-cash): Related to the amortization of non-cash intangible assets created as part of the allocation of the purchase price (PPA) on acquisitions; has no impact on the ongoing performance of the companies acquired.

6. Employee early retirement expenses: Provision for early retirement plan of employees at the Company's Israeli manufacturing sites

7. Revaluation of non-cash adjustment related to non-controlling interest: Relates to put options issued to non-controlling interests as part of historical business combinations which took place before January 1, 2010. The put options are presented as a liability at the present value of the future exercise price. The revaluation of these put options in Solutions is recognized under IFRS to Goodwill, but due to the acquisition of Solutions by the Company in 2017, which is treated from an accounting perspective as a "Business Combination Under Common Control", such revaluation is recorded as a profit or loss item in the financial reports of the Company. The revaluations of such put options have no bearing on the ongoing performance of the Company and are therefore adjusted for.

Exchange Rate Data for the Company's Principal Functional Currencies




June 30


Q2 Average


H1 Average

2020

2019

Change


2020

2019

Change


2020

2019

Change

EUR/USD

1.120

1.138

(1.5%)


1.100

1.124

(2.2%)


1.101

1.130

(2.6%)

USD/BRL

5.476

3.832

(42.9%)


5.839

3.919

(37.5%)


4.923

3.845

(28.1%)

USD/PLN

3.981

3.734

(6.6%)


4.096

3.812

(7.5%)


4.008

3.801

(5.5%)

USD/ZAR

17.241

14.140

(21.9%)


17.976

14.407

(24.8%)


16.664

14.213

(17.2%)

AUD/USD

0.684

0.703

(2.6%)


0.655

0.700

(6.5%)


0.656

0.706

(7.1%)

GBP/USD

1.227

1.270

(3.4%)


1.241

1.285

(3.5%)


1.260

1.294

(2.6%)

USD/ILS

3.466

3.566

2.8%


3.516

3.595

2.2%


3.507

3.620

3.1%

USD LIBOR 3M

0.30%

2.32%

(87.0%)


0.60%

2.51%

(76.1%)


1.08%

2.69%

(59.9%)


June 30


Q2 Average


H1 Average

2020

2019

Change


2020

2019

Change


2020

2019

Change

USD/RMB

7.080

6.875

3.0%


7.085

6.816

3.9%


7.029

6.780

3.7%

EUR/RMB

7.931

7.821

1.4%


7.791

7.661

1.7%


7.739

7.661

1.0%

RMB/BRL

0.774

0.557

(38.8%)


0.761

0.575

(32.3%)


0.700

0.567

(23.5%)

RMB/PLN

0.562

0.543

(3.5%)


0.559

0.559

0.0%


0.570

0.561

(1.7%)

RMB/ZAR

0.411

0.486

15.5%


0.394

0.473

16.7%


0.422

0.477

11.6%

AUD/RMB

4.846

4.832

0.3%


4.638

4.773

(2.8%)


4.612

4.790

(3.7%)

GBP/RMB

8.689

8.734

(0.5%)


8.790

8.762

0.3%


8.857

8.773

1.0%

RMB/ILS

0.490

0.519

5.6%


0.496

0.527

5.9%


0.499

0.534

6.6%

[1] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below "Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements".

[2] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below "Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements".

Contact


Ben Cohen

Zhujun Wang

Global Investor Relations

China Investor Relations

Email: ir@adama.com

Email: irchina@adama.com

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/adama-reports-second-quarter-results-returns-to-growth-despite-covid-19-headwinds-301115541.html

SOURCE ADAMA Ltd.